logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Nuss, John
    Born in August 1958
    Individual (2 offsprings)
    Officer
    icon of calendar 2024-04-17 ~ now
    OF - Director → CIF 0
  • 2
    Mohan, Raju
    Born in November 1956
    Individual (4 offsprings)
    Officer
    icon of calendar 2018-07-20 ~ now
    OF - Director → CIF 0
    Raju Mohan
    Born in November 1956
    Individual (4 offsprings)
    Person with significant control
    icon of calendar 2018-07-20 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 3
    LAW 2357 LIMITED - 2002-08-16
    icon of address5, New Street Square, London, United Kingdom
    Active Corporate (6 parents, 1042 offsprings)
    Equity (Company account)
    2 GBP2024-04-30
    Officer
    icon of calendar 2020-09-01 ~ now
    OF - Secretary → CIF 0
Ceased 3
  • 1
    Krueger, Christopher W.
    Biotech Executive born in February 1968
    Individual
    Officer
    icon of calendar 2021-02-26 ~ 2024-04-17
    OF - Director → CIF 0
  • 2
    Subramaniam, Somasundaram
    Venture Capital born in August 1954
    Individual (10 offsprings)
    Officer
    icon of calendar 2018-07-20 ~ 2021-02-26
    OF - Director → CIF 0
    Somasundaram Subramaniam
    Born in August 1954
    Individual (10 offsprings)
    Person with significant control
    icon of calendar 2018-07-20 ~ 2020-04-01
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 3
    ENFRANCHISE SECRETARIAL SERVICES LIMITED - 1992-02-04
    icon of address125, Wood Street, London, United Kingdom
    Active Corporate (6 parents, 220 offsprings)
    Equity (Company account)
    2 GBP2024-03-31
    Officer
    2018-07-20 ~ 2020-08-31
    PE - Secretary → CIF 0
parent relation
Company in focus

ZOMAGEN BIOSCIENCES LTD

Previous name
LUCIDUS THERAPEUTICS LTD - 2018-11-15
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
22023-01-01 ~ 2023-12-31
22022-01-01 ~ 2022-12-31
Fixed Assets - Investments
87,330 GBP2023-12-31
87,330 GBP2022-12-31
Fixed Assets
87,330 GBP2023-12-31
87,330 GBP2022-12-31
Debtors
Current
4,300,789 GBP2023-12-31
2,568,510 GBP2022-12-31
Cash at bank and in hand
807,411 GBP2022-12-31
Current Assets
4,300,789 GBP2023-12-31
3,375,921 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-54,693,520 GBP2023-12-31
Net Current Assets/Liabilities
-50,392,731 GBP2023-12-31
-34,446,568 GBP2022-12-31
Total Assets Less Current Liabilities
-50,305,401 GBP2023-12-31
-34,359,238 GBP2022-12-31
Net Assets/Liabilities
-50,305,401 GBP2023-12-31
-34,359,238 GBP2022-12-31
Equity
Called up share capital
921 GBP2023-12-31
921 GBP2022-12-31
921 GBP2022-01-01
Capital redemption reserve
151,342 GBP2022-12-31
151,342 GBP2022-01-01
Other miscellaneous reserve
6,132,749 GBP2023-12-31
6,132,749 GBP2022-12-31
6,132,749 GBP2022-01-01
Retained earnings (accumulated losses)
-56,439,091 GBP2023-12-31
-40,644,270 GBP2022-12-31
-16,772,147 GBP2022-01-01
Equity
-50,305,401 GBP2023-12-31
-34,359,238 GBP2022-12-31
-10,487,115 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
-15,946,163 GBP2023-01-01 ~ 2023-12-31
-23,872,123 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
-15,946,163 GBP2023-01-01 ~ 2023-12-31
-23,872,123 GBP2022-01-01 ~ 2022-12-31
Amounts Owed by Group Undertakings
Current
2,197,500 GBP2022-12-31
Other Debtors
Current
2,190,438 GBP2023-12-31
2,339 GBP2022-12-31
Prepayments/Accrued Income
Current
2,110,351 GBP2023-12-31
368,671 GBP2022-12-31
Trade Creditors/Trade Payables
Current
634,940 GBP2023-12-31
1,160,862 GBP2022-12-31
Amounts owed to group undertakings
Current
53,103,973 GBP2023-12-31
34,442,586 GBP2022-12-31
Other Creditors
Current
205,854 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
954,607 GBP2023-12-31
2,013,187 GBP2022-12-31
Creditors
Current
54,693,520 GBP2023-12-31
37,822,489 GBP2022-12-31
  • ZOMAGEN BIOSCIENCES LTD
    Info
    LUCIDUS THERAPEUTICS LTD - 2018-11-15
    Registered number 11475190
    icon of address5 New Street Square, London EC4A 3TW
    PRIVATE LIMITED COMPANY incorporated on 2018-07-20 (7 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-07-19
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.